Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2NIH 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Lymphoma 8Recurrence 3Lymphoma, Follicular 3Leukemia, Lymphocytic, Chronic, B-Cell 3Lymphoma, B-Cell, Marginal Zone 2Leukemia 2Waldenstrom Macroglobulinemia 1Stomach Neoplasms 1Hodgkin Disease 1

Interventions

Rituximab 19Cyclophosphamide 12Peripheral Blood Stem Cell Transplantation 10Filgrastim 10fludarabine phosphate 9Bortezomib 9Radiotherapy 8Cyclosporine 8tanespimycin 6Prednisone 6Magnetic Resonance Spectroscopy 6Etoposide 6Vorinostat 5Vincristine 5Lenalidomide 5Indium 5Ifosfamide 5temsirolimus 4bryostatin 1 4alvocidib 4Paclitaxel 4Interferon-alpha 4Gemcitabine 4Doxorubicin 4Cytarabine 4Busulfan 4sargramostim 3ibrutinib 3apolizumab 3aldesleukin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Lymphoma, B-Cell, Marginal Zone × Chlorambucil × Clear all
NCT00003639 2013-09-17

Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
200 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT00608374 2013-08-26

Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic Lymphoma

National Cancer Institute (NCI)

Phase 3 Completed
400 enrolled
Lymphoid

Lymphoma, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡